Source: Business Wire

Press Release: Lead Pharma : Steroid Hormone Receptor ERR1 (Estrogen Receptor-Like 1 or Estrogen-Related Receptor Alpha or ERR-Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or ESRRA or ERR1) - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Steroid Hormone Receptor ERR1 (Estrogen Receptor-Like 1 or Estrogen-Related Receptor Alpha or ERR-Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or ESRRA or ERR1) - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Steroid Hormone Receptor ERR1 (Estrogen Receptor-Like 1 or Estrogen-Related Receptor Alpha or ERR-Alpha or Nucl

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Frans van den Berg's photo - CEO of Lead Pharma

CEO

Frans van den Berg

CEO Approval Rating

88/100

Read more